Skip to content

Pilot Study in a Company in Maine-et-Loire to Evaluate the Feasibility, Acceptability, and Impact on the Participation Rate of Awareness of Colorectal Cancer Screening by Occupational Health Teams

Pilot Study in a Company in Maine-et-Loire to Evaluate the Feasibility, Acceptability, and Impact on the Participation Rate of Awareness of Colorectal Cancer Screening by Occupational Health Teams

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03458949
Enrollment
1400
Registered
2018-03-08
Start date
2018-06-18
Completion date
2021-01-31
Last updated
2018-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Brief summary

The main objective of this pilot study is to implement an awareness campaign for colorectal cancer screening in the workplace, in partnership with the staff of the occupational health service of one of the largest companies in Maine-Loire , and to evaluate the impact of this action on the participation rate of colorectal cancer screening among employees.

Interventions

awareness campaign for colorectal cancer screening in the workplace

Sponsors

University Hospital, Angers
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to 66 Years
Healthy volunteers
Yes

Inclusion criteria

* The study population is made up of the employees of the CHU d'Angers included in the target population of organized colorectal cancer screening in the Maine-et-Loire so employees aged 50 and over.

Exclusion criteria

* The criteria for non-inclusion are those of organized screening for colorectal cancer taking into account the active population: * Age \<50 years and\> 67 years * Personal or family history of polyps or colorectal cancer * Personal history of intestinal disease already undergoing colonoscopy surveillance (chronic inflammatory bowel disease, HNPCC syndrome, familial adenomatous polyposis) * Known genetic disease with risk of developing colorectal cancer.

Design outcomes

Primary

MeasureTime frameDescription
variation of the rate of participation in colorectal cancer screening2 yearseffective variation (after versus prior to awareness raising) of the overall rate of participation in colorectal cancer screening among employees of the company after 2 years.

Countries

France

Contacts

Primary ContactFrançois-Xavier Caroli-Bosc, MDPhD
FX.Caroli-Bosc@chu-angers.fr+33 2 41 35 60 54

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026